Infectious risk stratification in multiple sclerosis patients receiving immunotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 2328-9503|4|12|909-914

ISSN： 2328-9503

Source： Annals Of Clinical And Translational Neurology, Vol.4, Iss.12, 2017-12, pp. : 909-914

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Infectious Basis for Multiple Sclerosis: Perspectives on the Role of Chlamydia pneumoniae and Other Agents

By Jr H.M.   Sriram S.  

BioDrugs, Vol. 15, Iss. 3, 2001-03 ,pp. : 199-206

Adis International

Access to resources Recommend Favorite

The effects of intramuscular interferon beta-Ia in patients at high risk for development of multiple sclerosis: A post hoc analysis of data from CHAMPS

By O'Connor P.  

Clinical Therapeutics, Vol. 25, Iss. 11, 2003-11 ,pp. : 2865-2874

Elsevier

Access to resources Recommend Favorite

Improving Survival in Patients with High-Risk and Metastatic Melanoma: Immunotherapy Leads the Way

By Agarwala S.S.  

American Journal of Clinical Dermatology, Vol. 4, Iss. 5, 2003-01 ,pp. : 333-346

Adis International

Access to resources Recommend Favorite

Effects of inpatient rehabilitation in multiple sclerosis patients with moderate disability

By Vikman T.   Fielding P.   Lindmark B.   Fredrikson S.  

Advances in Physiotherapy, Vol. 10, Iss. 2, 2008-01 ,pp. : 58-65

Informa Healthcare

Access to resources Recommend Favorite

A multiple sclerosis‐like disorder in patients with OPA1 mutations

By  

Annals Of Clinical And Translational Neurology, Vol. 3, Iss. 9, 2016-09 ,pp. : 723-729

John Wiley & Sons Inc

Access to resources Recommend Favorite